Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Dexcom (DXCM) Shares Issued (2016 - 2026)

Dexcom has reported Shares Issued over the past 17 years, most recently at $12.7 million for Q1 2026.

  • Quarterly Shares Issued fell 10.56% to $12.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $26.6 million through Mar 2026, down 8.28% year-over-year, with the annual reading at $28.1 million for FY2025, 0.35% changed from the prior year.
  • Shares Issued was $12.7 million for Q1 2026 at Dexcom, down from $13.9 million in the prior quarter.
  • Over five years, Shares Issued peaked at $14.8 million in Q3 2024 and troughed at $10.1 million in Q1 2022.
  • The 5-year median for Shares Issued is $13.4 million (2024), against an average of $13.1 million.
  • Year-over-year, Shares Issued grew 21.78% in 2023 and then decreased 10.56% in 2026.
  • A 5-year view of Shares Issued shows it stood at $12.4 million in 2022, then increased by 15.32% to $14.3 million in 2023, then increased by 3.5% to $14.8 million in 2024, then decreased by 6.08% to $13.9 million in 2025, then dropped by 8.63% to $12.7 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Shares Issued are $12.7 million (Q1 2026), $13.9 million (Q3 2025), and $14.2 million (Q1 2025).